Theragnostic Radionuclide Pairs for Prostate Cancer Management: <sup>64</sup>Cu/<sup>67</sup>Cu, Can Be a Budding Hot Duo
Prostate cancer (PCa) is one of the preeminent causes of mortality in men worldwide. Theragnostic, a combination of therapy and diagnostic, using radionuclide pairs to diagnose and treat disease, has been shown to be a promising approach for combating PCa. In PCa patients, bone is one of the most co...
Na minha lista:
| Principais autores: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI AG
2022-11-01
|
| 叢編: | Biomedicines |
| 主題: | |
| 在線閱讀: | https://www.mdpi.com/2227-9059/10/11/2787 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|